U.S. government taps GlaxoSmithKline for new antibiotics

May 22, 2013 11:38 AM

8 0

U.S. government taps GlaxoSmithKline for new antibiotics

LONDON (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism.

The collaboration, the first of its kind between Washington and a drug company, will allow funding to move around GSK's antibiotics portfolio rather than focusing on a single drug candidate.

Also read: Irish Court Orders Russian Oligarch's Assets Unfrozen

Read more

To category page

Loading...